• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

mPAL的克隆与特性分析,mPAL是一种在增殖细胞中表达的新型Shc SH2结构域结合蛋白。

Cloning and characterization of mPAL, a novel Shc SH2 domain-binding protein expressed in proliferating cells.

作者信息

Schmandt R, Liu S K, McGlade C J

机构信息

Ontario Cancer Institute, University of Toronto, Canada.

出版信息

Oncogene. 1999 Mar 11;18(10):1867-79. doi: 10.1038/sj.onc.1202507.

DOI:10.1038/sj.onc.1202507
PMID:10086341
Abstract

Shc adaptor proteins play a role in linking activated cell surface receptors to the Ras signaling pathway in response to receptor mediated tyrosine kinase activation. While the function of Shc in the activation of the Ras pathway via binding to Grb2 has been well characterized, it is becoming increasingly apparent that Shc participates in additional signaling pathways through interactions with other cytoplasmic proteins. Using the yeast two-hybrid system, we have identified a unique Shc binding protein designated PAL (Protein expressed in Activated Lymphocytes) with no similarity to other known proteins. mPAL binds specifically to the Shc SH2 domain and unlike previously described Shc SH2 domain-protein interactions, the association of mPAL and Shc is phosphotyrosine-independent. Both mPAL RNA and protein expression are restricted to tissues containing actively dividing cells and proliferating cells in culture. mPAL expression is induced upon growth factor stimulation and is down-regulated upon growth inhibition. This pattern, and timing of mPAL expression and its association with the Shc adaptor molecule suggests a role for this protein in signaling pathways governing cell cycle progression.

摘要

Shc衔接蛋白在响应受体介导的酪氨酸激酶激活时,参与将活化的细胞表面受体与Ras信号通路相连接。虽然Shc通过与Grb2结合在激活Ras通路中的功能已得到充分表征,但越来越明显的是,Shc通过与其他细胞质蛋白相互作用参与额外的信号通路。利用酵母双杂交系统,我们鉴定出一种独特的Shc结合蛋白,命名为PAL(活化淋巴细胞中表达的蛋白),它与其他已知蛋白没有相似性。mPAL特异性结合Shc的SH2结构域,与先前描述的Shc SH2结构域 - 蛋白相互作用不同,mPAL与Shc的结合不依赖于磷酸酪氨酸。mPAL的RNA和蛋白表达均局限于含有活跃分裂细胞和培养中增殖细胞的组织。mPAL的表达在生长因子刺激时被诱导,在生长抑制时被下调。mPAL表达的这种模式、时间及其与Shc衔接分子的关联表明该蛋白在调控细胞周期进程的信号通路中发挥作用。

相似文献

1
Cloning and characterization of mPAL, a novel Shc SH2 domain-binding protein expressed in proliferating cells.mPAL的克隆与特性分析,mPAL是一种在增殖细胞中表达的新型Shc SH2结构域结合蛋白。
Oncogene. 1999 Mar 11;18(10):1867-79. doi: 10.1038/sj.onc.1202507.
2
Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc.Gads是一种含有SH2和SH3结构域的新型衔接蛋白,可与酪氨酸磷酸化的Shc结合。
Oncogene. 1998 Dec 17;17(24):3073-82. doi: 10.1038/sj.onc.1202337.
3
A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.一个保守的氨基末端Shc结构域与活化受体和磷酸肽中的磷酸酪氨酸基序结合。
Curr Biol. 1995 Apr 1;5(4):404-12. doi: 10.1016/s0960-9822(95)00081-9.
4
Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.Shc磷酸酪氨酸结合结构域主要与表皮生长因子受体相互作用,并在完整细胞中介导Ras激活。
Mol Endocrinol. 1998 Apr;12(4):536-43. doi: 10.1210/mend.12.4.0094.
5
A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.一种具有保守的Src同源2结构域和磷酸酪氨酸结合结构域的哺乳动物衔接蛋白与Shc相关,且在脑中特异性表达。
Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2729-34. doi: 10.1073/pnas.93.7.2729.
6
A family of Shc related proteins with conserved PTB, CH1 and SH2 regions.一个具有保守的PTB、CH1和SH2区域的Shc相关蛋白家族。
Oncogene. 1996 Aug 1;13(3):633-41.
7
Formation of Shc/Grb2- and Crk adaptor complexes containing tyrosine phosphorylated Cbl upon stimulation of the B-cell antigen receptor.在B细胞抗原受体受到刺激时,形成含有酪氨酸磷酸化Cbl的Shc/Grb2和Crk衔接蛋白复合物。
Oncogene. 1996 Jul 18;13(2):381-9.
8
Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the ErbB-2 kinase.对ErbB-2激酶激活Shc/Grb-2信号通路中涉及的蛋白质-蛋白质相互作用的分析。
Oncogene. 1995 Oct 19;11(8):1519-29.
9
The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions.Shc衔接蛋白在保守的双酪氨酸残基(Y239/240)处高度磷酸化,这些残基介导蛋白质-蛋白质相互作用。
Curr Biol. 1996 Nov 1;6(11):1435-44. doi: 10.1016/s0960-9822(96)00748-8.
10
The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.ShcC衔接蛋白的src同源2结构域和磷酸酪氨酸结合结构域作为表皮生长因子受体促有丝分裂信号传导的抑制剂发挥作用。
J Biol Chem. 1998 Aug 7;273(32):20431-7. doi: 10.1074/jbc.273.32.20431.

引用本文的文献

1
The Roles of SHCBP1 in Cancer Hallmarks: Molecular Mechanisms and Therapeutic Implications.SHCBP1在癌症特征中的作用:分子机制与治疗意义
Int J Mol Sci. 2025 Sep 9;26(18):8778. doi: 10.3390/ijms26188778.
2
β-catenin as a key regulator of the cisplatin response in tumor cells.β-连环蛋白作为肿瘤细胞中顺铂反应的关键调节因子。
Clin Exp Med. 2025 Jun 15;25(1):206. doi: 10.1007/s10238-025-01757-1.
3
Peptide Family Promotes Brain Cell Rejuvenation and Improved Cognition through Peripheral Delivery.肽家族通过外周给药促进脑细胞年轻化并改善认知。
ACS Omega. 2025 Mar 31;10(13):13236-13250. doi: 10.1021/acsomega.4c10849. eCollection 2025 Apr 8.
4
SHCBP1 is a novel regulator of PLK1 phosphorylation and promotes prostate cancer bone metastasis.SHCBP1是PLK1磷酸化的新型调节因子,并促进前列腺癌骨转移。
MedComm (2020). 2025 Feb 13;6(2):e70082. doi: 10.1002/mco2.70082. eCollection 2025 Feb.
5
SHCBP1 promotes cisplatin resistance of ovarian cancer through AKT/mTOR/Autophagy pathway.SHCBP1通过AKT/mTOR/自噬途径促进卵巢癌的顺铂耐药性。
Apoptosis. 2025 Feb;30(1-2):83-98. doi: 10.1007/s10495-024-02027-3. Epub 2024 Oct 13.
6
The dynamic role of nucleoprotein SHCBP1 in the cancer cell cycle and its potential as a synergistic target for DNA-damaging agents in cancer therapy.核蛋白 SHCBP1 在癌细胞周期中的动态作用及其作为癌症治疗中 DNA 损伤剂协同靶标的潜力。
Cell Commun Signal. 2024 Feb 16;22(1):131. doi: 10.1186/s12964-024-01513-0.
7
Therapeutic potential of SHCBP1 inhibitor AZD5582 in pancreatic cancer treatment.SHCBP1 抑制剂 AZD5582 在胰腺癌治疗中的治疗潜力。
Cancer Sci. 2024 Mar;115(3):820-835. doi: 10.1111/cas.16059. Epub 2023 Dec 27.
8
SHCBP1 Promotes the Proliferation of Breast Cancer Cells by Inhibiting CXCL2.SHCBP1通过抑制CXCL2促进乳腺癌细胞增殖。
J Cancer. 2023 Oct 16;14(18):3444-3456. doi: 10.7150/jca.88072. eCollection 2023.
9
SHCBP1 contributes to the proliferation and self‑renewal of cervical cancer cells and activation of the NF‑κB signaling pathway through EIF5A.SHCBP1通过EIF5A促进宫颈癌细胞的增殖和自我更新以及NF-κB信号通路的激活。
Oncol Lett. 2023 Apr 21;25(6):246. doi: 10.3892/ol.2023.13832. eCollection 2023 Jun.
10
A Study of Combined Genotype Effects of SHCBP1 on Wool Quality Traits in Chinese Merino.中国美利奴羊 SHCBP1 基因型组合效应对羊毛品质性状的研究。
Biochem Genet. 2023 Apr;61(2):551-564. doi: 10.1007/s10528-022-10268-7. Epub 2022 Aug 20.